Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Prospective, Randomized, Double-blind, Sham-controlled Clinical Study to Evaluate Safety and Effectiveness of a Transcutaneous, High-frequency, Amplitude-modulated, Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Subjects With Overactive Bladder (OAB)

NCT01369485 is registered in ClinicalTrials.gov with Ethicon Endo-Surgery as lead sponsor.

NCT NCT01369485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01369485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Prospective, Randomized, Double-blind, Sham-controlled Clinical Study to Evaluate Safety and Effectiveness of a Transcutaneous, High-frequency, Amplitude-modulated, Non-invasive Neuromodulation Device on Urgency Urinary Incontinence in Subjects With Overactive Bladder (OAB)
Lead sponsor
Ethicon Endo-Surgery
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2011
Completion date
December 31, 2013
Enrollment
163 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder